Credit Suisse Ag G1 Therapeutics, Inc. Transaction History

Credit Suisse Ag

$101 Billion
Q1 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 May 10, 2023	BUY	$2.57 - $8.16 $10,313 - $32,746	4,013 Added 11.6%	38,602 $103,000
Q4 2022 Feb 13, 2023	BUY	$5.19 - $13.5 $179,516 - $466,951	34,589 New	34,589 $187,000
Q2 2022 Aug 12, 2022	SELL	$4.04 - $8.51 $89,397 - $188,309	-22,128 Reduced 100.0%	1 $0
Q1 2022 May 16, 2022	BUY	$7.6 - $11.02 $5,654 - $8,198	744 Added 3.48%	22,129 $168,000
Q4 2021 Feb 14, 2022	SELL	$10.16 - $16.17 $61,234 - $97,456	-6,027 Reduced 21.99%	21,385 $218,000
Q3 2021 Nov 12, 2021	BUY	$13.16 - $22.47 $92,567 - $158,053	7,034 Added 34.52%	27,412 $367,000
Q2 2021 Aug 16, 2021	SELL	$19.57 - $26.32 $51,743 - $69,590	-2,644 Reduced 11.48%	20,378 $448,000
Q1 2021 May 14, 2021	SELL	$17.58 - $32.59 $858,220 - $1.59 Million	-48,818 Reduced 67.95%	23,022 $554,000
Q4 2020 Feb 12, 2021	SELL	$10.99 - $20.4 $173,861 - $322,728	-15,820 Reduced 18.05%	71,840 $1.29 Million
Q3 2020 Nov 13, 2020	BUY	$11.55 - $23.75 $485,758 - $998,853	42,057 Added 92.22%	87,660 $1.01 Million
Q2 2020 Aug 12, 2020	BUY	$9.57 - $24.37 $221,631 - $564,384	23,159 Added 103.19%	45,603 $1.11 Million
Q1 2020 May 13, 2020	SELL	$9.07 - $26.32 $50,909 - $147,734	-5,613 Reduced 20.01%	22,444 $248,000
Q4 2019 Feb 12, 2020	BUY	$20.54 - $31.0 $63,838 - $96,348	3,108 Added 12.46%	28,057 $742,000
Q3 2019 Nov 12, 2019	BUY	$22.78 - $40.58 $172,763 - $307,758	7,584 Added 43.67%	24,949 $568,000
Q2 2019 Aug 14, 2019	BUY	$16.03 - $31.1 $36,708 - $71,219	2,290 Added 15.19%	17,365 $532,000
Q1 2019 May 14, 2019	BUY	$14.4 - $21.45 $51,753 - $77,091	3,594 Added 31.3%	15,075 $250,000
Q4 2018 Feb 13, 2019	SELL	$16.51 - $51.33 $127,259 - $395,651	-7,708 Reduced 40.17%	11,481 $219,000
Q3 2018 Nov 13, 2018	BUY	$43.15 - $67.97 $89,363 - $140,765	2,071 Added 12.1%	19,189 $1 Million
Q2 2018 Aug 14, 2018	BUY	$35.06 - $51.17 $324,094 - $473,015	9,244 Added 117.4%	17,118 $744,000
Q1 2018 May 15, 2018	BUY	$19.05 - $41.76 $149,999 - $328,818	7,874 New	7,874 $292,000

Others Institutions Holding GTHX

# of Institutions

Shares Held

3.55M

Call Options Held

11.7K

Put Options Held

View Full List

About G1 Therapeutics, Inc.

Ticker GTHX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,746,800
Market Cap $306M
Description
G1 Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of small molecule therapeutics for the treatment of patients with cancer. The company offers COSELA, which helps to decrease chemotherapy-induced myelosuppression in adult patients when administered prior to a platinum/...

More about GTHX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Credit Suisse Ag, based on Form 13F filings with the SEC.

News

Stay updated on Credit Suisse Ag with notifications on news.

Account